HER2-low metastases of HER2-negative primary tumors: a single institution analysis of intertumoral and internodal heterogeneity in node-positive breast cancer

OBJECTIVE: HER2 status in breast cancer is an essential parameter in individual therapeutic decision-making and is routinely assessed in primary tumors in accordance with international recommendations. Reports of HER2 heterogeneity raise the question of basing treatment decisions on HER2 status in m...

Descripción completa

Detalles Bibliográficos
Autores principales: Pellas, Ulrika, Bauer, Annette, Baroš, Ilija Vladimir, Fattorini, Caterina, Tot, Tibor
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10362429/
https://www.ncbi.nlm.nih.gov/pubmed/37483511
http://dx.doi.org/10.3389/fonc.2023.1167567

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10362429/
https://www.ncbi.nlm.nih.gov/pubmed/37483511
http://dx.doi.org/10.3389/fonc.2023.1167567

Ejemplares similares